The Procter & Gamble Company revised earnings guidance for the fiscal 2023. The company raised its guidance for fiscal 2023 all-in sales to a range of down 1% to in-line versus the prior fiscal year from a prior range of down 3% to down 1%. The Company also raised its outlook for organic sales growth to a range of 4% to 5% versus the prior fiscal year from a prior growth range of 3% to 5%.

The company maintained its outlook for fiscal 2023 diluted net earnings per share growth in the range of in-line to up 4% versus fiscal 2022 EPS of $5.81.